Jasmin Kee | Cell and Gene
Independent Consultant

Jasmin Kee, Cell and Gene, Independent Consultant

Dr. Jasmin Kee is a process and manufacturing operations specialist with over 15 years’ experience in the Cell and Gene Therapy industry. She has worked for companies including Intercytex, Organogenesis, Reneuron and Cell Medica and now provides consultancy in areas including manufacturing process design, operational strategic planning and design of cGMP facilities. Jasmin started her career as a Process Engineer and moved into roles of increasing responsibility including Head of Engineering and VP of Manufacturing Operation (EU). She has built teams responsible for manufacturing process design, scale-up, automation and technology transfer for clinical trial and commercial products. She has developed cost of goods models and designed cGMP manufacturing facilities in the US and UK. Her experience includes development and manufacturing of tissue engineered, stem cell and CAR-T products as well as blood plasma products and consumer goods. She also serves as an advisory board member at UCL to support the development of graduates entering the industry and course content in the Biochemical Engineering Department. Jasmin is known for delivering solutions to meet short and long term milestones, creative thinking and a hands-on approach.


Conference Day 1 - Tuesday 31st March 2020 @ 17:20

Panel discussion: process development for next generation therapeutics

Conference Day 2 - Wednesday 1st April 2020 @ 16:30

Panel discussion: moving towards ‘smart’ and ‘flexible’ integrated process pipelines

a. What are the common bioprocess units suitable for all ATMP manufacture – technology and scale perspectives? b..…and what are the specialisations when it comes to different therapy types? i.Technologiesii.Tools iii. Data c. Inherently variable field eliminating sources of systemic uncertainty towards process streamliningd. Whole-process intensification in cell therapy manufacturing: room to improve
last published: 04/Jun/20 08:25 GMT

back to speakers